Quick Answer
Caribou Biosciences, Inc. reported Shares Outstanding of 95.14 million shares for fiscal year 2025.
Caribou Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 95.14M | +3.0% |
| 2024 | 92.38M | +4.4% |
| 2023 | 88.45M | +44.9% |
| 2022 | 61.03M | +1.3% |
| 2021 | 60.26M | +520.6% |
| 2020 | 9.71M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 93.47M | +3.2% | +0.4% |
| June 30, 2025 | 93.12M | +3.1% | +0.1% |
| March 31, 2025 | 93.00M | +3.0% | +0.7% |
| December 31, 2024 | 92.38M | +4.4% | +2.0% |
| September 30, 2024 | 90.55M | +2.4% | +0.2% |
| June 30, 2024 | 90.36M | +36.7% | +0.1% |
| March 31, 2024 | 90.31M | +47.3% | +2.1% |
| December 31, 2023 | 88.45M | +44.9% | +0.0% |
- Caribou Biosciences, Inc. showed an increase of +3.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Caribou Biosciences, Inc.’s shares outstanding has grown by 879.8% (from 9.71 million shares to 95.14 million shares).
- The most recent figure is from Caribou Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: